Chronic Kidney Disease

Nishank Jain, MBBS - Joseph V. Bonventre Career Development Grant (2018)

Name: Nishank Jain, MBBS

Institution: University of Arkansas for Medical Sciences

Grant: Joseph V. Bonventre Career Development Grant (2018)

Project Title: A Mechanistic Study in Patients with Non-Dialysis Chronic Kidney Disease to Investigate Altered Platelet Response to Antiplatelet Therapy (CKD-Platelet Study)
 

How would you sum up your research in one sentence?

Ke Wang, MD - Joseph A. Carlucci Research Fellowship Award (2018)

Name: Ke Wang, MD

Institution: University of Washington

Grant: Joseph A. Carlucci Research Fellowship Award (2018)

Project Title: Proximal Tubule Secretion: A Complementary Marker to GFR in Kidney Disease
 

How would you sum up your research in one sentence?

Changes to chronic kidney care Medicare coverage in passed House legislation

A last-minute addition to the legislative package in the House would extend by three months the period people with chronic kidney failure must wait before they become eligible for Medicare coverage. Lawmakers inserted the change, which is projected to save the government $290 million over a decade, to help pay for their slew of new initiatives aimed at curbing opioid misuse.  The bill passed the House by a vote of 396-14.

The Sixth Annual Kidney Health Initiative Stakeholders Meeting

khi may meeting.PNGThe Kidney Health Initiative (KHI), a public-private partnership between the American Society of Nephrology (ASN) and the U.S. Food and Drug Administration (FDA), advances its mission of facilitating innovation and patient safety in kidney disease through its collaborative partnerships with 90 organizations, working together in the largest collaborative body in the kidney community.

Communities Weekly Rewind: IgG1-lambda mesangial proliferative GN

Query
PGNMID is an uncommon diagnosis, and without any evidence of a circulating paraprotein or cell clonality in the bone marrow, what is the pathophysiology of this lesion and how do we go about treating it?

Communities Weekly Rewind: Hope and Innovation in Nephrology

Months of efforts by ASN staff culminated on April 26, 2018, when ASN signed a Memorandum of Understanding with the Department of Health and Human Services to establish the Kidney Innovation Accelerator, KidneyX.

Newly Launched KidneyX Aims to Accelerate the Commercialization of Innovative Therapies in Kidney Care

ASN and the U.S. Department of Health and Human Services (HHS) have sent a clear signal in their desire to have new therapies in the kidney space through the signing of a Memorandum of Understanding establishing the Kidney Innovation Accelerator (KidneyX), a collaborative environment in which a community of researchers, innovators, and investors can participate.

ASN, along with 36 kidney organizations, signed letter to Senate Appropriations for additional kidney research funding at NIH

On Monday, April 23, the American Society of Nephrology and a record-setting coalition of 36 other organizations in the kidney community, authored a letter to the leadership of the House and Senate Appropriations Subcommittees that appropriate funds for the National Institutes of Health (NIH).

Communities Weekly Rewind: Normal Saline vs. Balanced Solution

This Communities discussion compared the results of two randomized clinical trials (SMART and SALT-ed) reported on in the New England Journal of Medicine that compared the effects of normal saline and a “balanced solution” in preventing AKI. Isotonic saline (0.9% NS) is the main crystalloid solution used for resuscitation of hypovolemic critically or non-critically ill patients.

U.S. Opioid Crisis: July Special Section


The July issue of Kidney News features a special section on the US opioid epidemic and the correlation with kidney disease.

 

Interactive Map

Pages